Picklejar Entertainment Group Inc. Stock Analysis NREG
Newregen, Inc. operates an anti-aging and stem cell center. The company is headquartered in Atlanta, Georgia. The company went IPO on 2013-01-09. The company operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. The company is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. The company offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. The company also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.
Read More Picklejar Entertainment Group Inc (NREG) Chart
Key Statistics of Picklejar Entertainment Group Inc (NREG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
262.63KP/E Ratio (TTM)
2.4952 Week Range
Market Cap
623.20KAvg. Volume
90.73KDividend Yield
-Financial Metrics & Statements of Picklejar Entertainment Group Inc (NREG)
FAQ's for Picklejar Entertainment Group Inc (NREG)
- According to Musaffa’s Shariah screening methodology, Picklejar Entertainment Group Inc (NREG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.